doi: 10.1159/000456660 55 VrcaVBMayerLSkrebFRaheliDMaruiS
A meta-analysis of 8 RCTs found that NAC supplementation significantly reduced fasting glucose (WMD: -5.84 mg/dL) and HbA1c (WMD: -0.27%) in people with metabolic conditions (Sarkaki et al., Clin Nutr ESPEN, 2021) [57]
Current pharmacotherapies, including GLP-1 receptor agonists (GLP-1RAs), primarily target a single receptor and signaling pathway
Pharmacy benefits managers are a middleman between the insurance companies, pharmacies, and manufacturers, explains Jamie Alan, PharmD, PhD, an associate professor of pharmacology and toxicology at Michigan State University in East Lansing
The amylin analogue pramlintide was licensed by the FDA in 2005 for patients with insulin-treated diabetes
Maximum LDL-C reduction occurred by 2 weeks after a single-dose of 140 mg of evolocumab and by 3 weeks after a single-dose of 420 mg of evolocumab